STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Cencora, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

COR reports that an affiliate intends to sell 5,096 shares of its common stock on the NYSE through Fidelity Brokerage Services LLC. The planned sale has an aggregate market value of 1,868,397.44, compared with 193,877,881 common shares outstanding.

The shares to be sold come from 1,333 shares acquired on 11/08/2024 via restricted stock vesting as compensation and 3,763 shares acquired on 11/18/2025 from an option granted on 11/13/2019 and paid for in cash. The seller, identified as Robert P. Mauch, has sold additional common shares during the past three months: 4,968 shares on 08/18/2025 for gross proceeds of 1,458,257.04; 5,097 shares on 09/18/2025 for 1,478,130.00; and 5,097 shares on 10/20/2025 for 1,665,699.60.

Positive
  • None.
Negative
  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for COR disclose?

The filing discloses an intended sale of 5,096 COR common shares on the NYSE through Fidelity Brokerage Services LLC, with an aggregate market value of 1,868,397.44.

How many COR shares are outstanding compared to the amount being sold?

The planned sale covers 5,096 shares, while the filing reports 193,877,881 common shares outstanding, indicating a very small fraction of total shares.

How were the COR shares being sold under this Form 144 acquired?

The seller acquired 1,333 shares on 11/08/2024 through restricted stock vesting as compensation, and 3,763 shares on 11/18/2025 by exercising an option granted on 11/13/2019 and paying in cash.

Who is selling COR shares and what sales occurred in the last 3 months?

Robert P. Mauch is listed as the seller. Over the past three months, he sold 4,968 shares on 08/18/2025 for 1,458,257.04, 5,097 shares on 09/18/2025 for 1,478,130.00, and 5,097 shares on 10/20/2025 for 1,665,699.60.

What trading plan or certification is referenced in the COR Form 144?

The signer represents that they do not know of any material adverse information about COR that has not been publicly disclosed and may indicate a Rule 10b5-1 trading plan date if applicable.

On which exchange will the COR shares be sold and through which broker?

The filing states that the common shares are expected to be sold on the NYSE through Fidelity Brokerage Services LLC, located in Smithfield, RI.

Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

70.11B
185.67M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN